nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—SLC5A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0616	0.0616	CbGpPWpGaD
Canagliflozin—SLC5A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0616	0.0616	CbGpPWpGaD
Canagliflozin—ABCC2—ABC-family proteins mediated transport—ABCG4—age related macular degeneration	0.0426	0.0426	CbGpPWpGaD
Canagliflozin—ABCC2—ABC-family proteins mediated transport—ABCA4—age related macular degeneration	0.0379	0.0379	CbGpPWpGaD
Canagliflozin—SLC5A1—Orphan transporters—CETP—age related macular degeneration	0.0288	0.0288	CbGpPWpGaD
Canagliflozin—SLC5A2—Orphan transporters—CETP—age related macular degeneration	0.0288	0.0288	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.028	0.028	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.028	0.028	CbGpPWpGaD
Canagliflozin—ALB—HDL-mediated lipid transport—CETP—age related macular degeneration	0.0203	0.0203	CbGpPWpGaD
Canagliflozin—ABCB1—ABC-family proteins mediated transport—ABCG4—age related macular degeneration	0.02	0.02	CbGpPWpGaD
Canagliflozin—SLC5A2—NRF2 pathway—SQSTM1—age related macular degeneration	0.0197	0.0197	CbGpPWpGaD
Canagliflozin—SLC5A1—NRF2 pathway—SQSTM1—age related macular degeneration	0.0197	0.0197	CbGpPWpGaD
Canagliflozin—ABCB1—ABC-family proteins mediated transport—ABCA4—age related macular degeneration	0.0178	0.0178	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.016	0.016	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.016	0.016	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.0142	0.0142	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.0142	0.0142	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.0142	0.0142	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.0142	0.0142	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—SERPING1—age related macular degeneration	0.0133	0.0133	CbGpPWpGaD
Canagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ELOVL4—age related macular degeneration	0.0133	0.0133	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—SERPING1—age related macular degeneration	0.0127	0.0127	CbGpPWpGaD
Canagliflozin—ALB—Lipoprotein metabolism—LIPC—age related macular degeneration	0.0121	0.0121	CbGpPWpGaD
Canagliflozin—ALB—Lipoprotein metabolism—CETP—age related macular degeneration	0.0116	0.0116	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—NMNAT1—age related macular degeneration	0.0113	0.0113	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—RDH8—age related macular degeneration	0.0113	0.0113	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—RDH8—age related macular degeneration	0.0113	0.0113	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—NMNAT1—age related macular degeneration	0.0113	0.0113	CbGpPWpGaD
Canagliflozin—ALB—HDL-mediated lipid transport—APOE—age related macular degeneration	0.0107	0.0107	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—RPE65—age related macular degeneration	0.00987	0.00987	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—RPE65—age related macular degeneration	0.00987	0.00987	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—NMNAT1—age related macular degeneration	0.00945	0.00945	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—NMNAT1—age related macular degeneration	0.00945	0.00945	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ELOVL4—age related macular degeneration	0.00826	0.00826	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ELOVL4—age related macular degeneration	0.00826	0.00826	CbGpPWpGaD
Canagliflozin—ALB—Lipid and lipoprotein metabolism—LIPC—age related macular degeneration	0.00801	0.00801	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—ABCA4—age related macular degeneration	0.00795	0.00795	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—ABCA4—age related macular degeneration	0.00795	0.00795	CbGpPWpGaD
Canagliflozin—ALB—Lipid and lipoprotein metabolism—CETP—age related macular degeneration	0.00773	0.00773	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—NMNAT1—age related macular degeneration	0.0073	0.0073	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00702	0.00702	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00702	0.00702	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—RHO—age related macular degeneration	0.00692	0.00692	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—RHO—age related macular degeneration	0.00692	0.00692	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—SLC16A8—age related macular degeneration	0.00666	0.00666	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—SLC16A8—age related macular degeneration	0.00666	0.00666	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ELOVL4—age related macular degeneration	0.00638	0.00638	CbGpPWpGaD
Canagliflozin—ALB—Lipoprotein metabolism—APOE—age related macular degeneration	0.00617	0.00617	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.00592	0.00592	CbGpPWpGaD
Canagliflozin—UGT1A9—NRF2 pathway—SQSTM1—age related macular degeneration	0.00562	0.00562	CbGpPWpGaD
Canagliflozin—ABCC2—NRF2 pathway—SQSTM1—age related macular degeneration	0.00548	0.00548	CbGpPWpGaD
Canagliflozin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—age related macular degeneration	0.00545	0.00545	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.0053	0.0053	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—SLC16A8—age related macular degeneration	0.00514	0.00514	CbGpPWpGaD
Canagliflozin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—age related macular degeneration	0.00481	0.00481	CbGpPWpGaD
Canagliflozin—UGT1A9—PPARA activates gene expression—CD36—age related macular degeneration	0.00472	0.00472	CbGpPWpGaD
Canagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—age related macular degeneration	0.00462	0.00462	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00445	0.00445	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—CST3—age related macular degeneration	0.00433	0.00433	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—CST3—age related macular degeneration	0.00433	0.00433	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00419	0.00419	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.00412	0.00412	CbGpPWpGaD
Canagliflozin—ALB—Lipid and lipoprotein metabolism—APOE—age related macular degeneration	0.0041	0.0041	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.00404	0.00404	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00396	0.00396	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00396	0.00396	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—TGFBR1—age related macular degeneration	0.00388	0.00388	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—TGFBR1—age related macular degeneration	0.00388	0.00388	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—LIPC—age related macular degeneration	0.00341	0.00341	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—LIPC—age related macular degeneration	0.00341	0.00341	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.00339	0.00339	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—CRP—age related macular degeneration	0.00336	0.00336	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—CETP—age related macular degeneration	0.00329	0.00329	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—CETP—age related macular degeneration	0.00329	0.00329	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—F13B—age related macular degeneration	0.00324	0.00324	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—CD36—age related macular degeneration	0.00319	0.00319	CbGpPWpGaD
Canagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—age related macular degeneration	0.00319	0.00319	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—SERPING1—age related macular degeneration	0.00305	0.00305	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00304	0.00304	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00278	0.00278	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—CCL2—age related macular degeneration	0.00276	0.00276	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—NMNAT1—age related macular degeneration	0.0027	0.0027	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—C3—age related macular degeneration	0.00268	0.00268	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00267	0.00267	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—RAD51B—age related macular degeneration	0.00264	0.00264	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—LIPC—age related macular degeneration	0.00263	0.00263	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00255	0.00255	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CETP—age related macular degeneration	0.00254	0.00254	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—SLC16A8—age related macular degeneration	0.00246	0.00246	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00239	0.00239	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ELOVL4—age related macular degeneration	0.00236	0.00236	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00229	0.00229	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00219	0.00219	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00219	0.00219	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00213	0.00213	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00213	0.00213	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00211	0.00211	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00209	0.00209	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—APOE—age related macular degeneration	0.00208	0.00208	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—APOE—age related macular degeneration	0.00208	0.00208	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—CD36—age related macular degeneration	0.00198	0.00198	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—CD36—age related macular degeneration	0.00198	0.00198	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00196	0.00196	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—SLC16A8—age related macular degeneration	0.0019	0.0019	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00186	0.00186	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00186	0.00186	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—APOE—age related macular degeneration	0.00174	0.00174	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—APOE—age related macular degeneration	0.00174	0.00174	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00155	0.00155	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CD36—age related macular degeneration	0.00153	0.00153	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—VEGFA—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NMNAT1—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—APOE—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.00134	0.00134	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ELOVL4—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00115	0.00115	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SLC16A8—age related macular degeneration	0.000997	0.000997	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—LIPC—age related macular degeneration	0.000974	0.000974	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CETP—age related macular degeneration	0.00094	0.00094	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000921	0.000921	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000873	0.000873	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000764	0.000764	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—CD36—age related macular degeneration	0.00073	0.00073	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000674	0.000674	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000667	0.000667	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000664	0.000664	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000664	0.000664	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000586	0.000586	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CD36—age related macular degeneration	0.000565	0.000565	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000538	0.000538	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—LIPC—age related macular degeneration	0.00051	0.00051	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—APOE—age related macular degeneration	0.000498	0.000498	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CETP—age related macular degeneration	0.000492	0.000492	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000447	0.000447	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CETP—age related macular degeneration	0.000431	0.000431	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—VEGFA—age related macular degeneration	0.000347	0.000347	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CD36—age related macular degeneration	0.000296	0.000296	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000275	0.000275	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000266	0.000266	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—APOE—age related macular degeneration	0.000261	0.000261	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CD36—age related macular degeneration	0.000259	0.000259	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—APOE—age related macular degeneration	0.000229	0.000229	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CD36—age related macular degeneration	0.00016	0.00016	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—APOE—age related macular degeneration	0.000141	0.000141	CbGpPWpGaD
